This page lists the SEC filings reported by HHLR ADVISORS, LTD..
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D | 2020-09-14 | HILLHOUSE CAPITAL ADVISORS, LTD. | I-Mab | 10,586,008 | 6.8% | EDGAR |
| SC 13D/A | 2020-07-14 | HILLHOUSE CAPITAL ADVISORS, LTD. | BeiGene, Ltd. | 147,035,258 | 12.7% | EDGAR |
| SC 13D/A | 2020-06-24 | HILLHOUSE CAPITAL ADVISORS, LTD. | Cellular Biomedicine Group, Inc. | 235,214 | 1.2% | EDGAR |
| SC 13D/A | 2020-05-08 | HILLHOUSE CAPITAL ADVISORS, LTD. | China Biologic Products Holdings, Inc. | 2,962,076 | 7.7% | EDGAR |
| SC 13D/A | 2020-03-30 | HILLHOUSE CAPITAL ADVISORS, LTD. | Cellular Biomedicine Group, Inc. | 235,214 | 1.2% | EDGAR |
| SC 13D/A | 2020-02-21 | HILLHOUSE CAPITAL ADVISORS, LTD. | Cellular Biomedicine Group, Inc. | 235,214 | 1.2% | EDGAR |
| SC 13G/A | 2020-02-14 | HILLHOUSE CAPITAL ADVISORS, LTD. | iQIYI, Inc. | 326,862,409 | 14.9% | EDGAR |
| SC 13G/A | 2020-02-14 | HILLHOUSE CAPITAL ADVISORS, LTD. | Kiniksa Pharmaceuticals, Ltd. | 1,895,888 | 9.9% | EDGAR |
| SC 13G/A | 2020-02-14 | HILLHOUSE CAPITAL ADVISORS, LTD. | MOGU Inc. | 261,174,255 | 11.0% | EDGAR |
| SC 13G/A | 2020-02-14 | HILLHOUSE CAPITAL ADVISORS, LTD. | Apellis Pharmaceuticals, Inc. | 4,678,289 | 7.3% | EDGAR |
| SC 13G | 2020-02-14 | HILLHOUSE CAPITAL ADVISORS, LTD. | TAL Education Group | 9,151,656 | 6.9% | EDGAR |
| SC 13G | 2020-02-14 | HILLHOUSE CAPITAL ADVISORS, LTD. | Bilibili Inc. | 10,215,355 | 4.5% | EDGAR |
| SC 13G | 2020-02-14 | HILLHOUSE CAPITAL ADVISORS, LTD. | Gossamer Bio, Inc. | 5,911,541 | 9.0% | EDGAR |
| SC 13G | 2020-02-14 | HILLHOUSE CAPITAL ADVISORS, LTD. | Viela Bio, Inc. | 4,591,176 | 9.0% | EDGAR |
| SC 13D/A | 2020-01-30 | HILLHOUSE CAPITAL ADVISORS, LTD. | Cellular Biomedicine Group, Inc. | 235,214 | 1.2% | EDGAR |
| SC 13D/A | 2020-01-27 | HILLHOUSE CAPITAL ADVISORS, LTD. | China Biologic Products Holdings, Inc. | 2,962,076 | 7.7% | EDGAR |
| SC 13D | 2019-11-12 | HILLHOUSE CAPITAL ADVISORS, LTD. | Cellular Biomedicine Group, Inc. | 235,214 | 1.2% | EDGAR |
| SC 13D | 2019-09-19 | HILLHOUSE CAPITAL ADVISORS, LTD. | China Biologic Products Holdings, Inc. | 2,751,200 | 7.2% | EDGAR |
| SC 13D/A | 2019-04-02 | Hillhouse Capital Advisors, Ltd. | Enstar Group LTD | 543,487 | 3.0% | EDGAR |
| SC 13G/A | 2019-02-14 | Hillhouse Capital Advisors, Ltd. | iQIYI, Inc. | 7,929,712 | 0.4% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.